tyrosine has been researched along with tamoxifen in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.70) | 18.7374 |
| 1990's | 7 (25.93) | 18.2507 |
| 2000's | 11 (40.74) | 29.6817 |
| 2010's | 7 (25.93) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Hakim, AA | 1 |
| Chen, D; Ding, IY; el-Ashry, D; Kern, FG; Liu, Y | 1 |
| Arbell, A; Danilenko, M; Karas, M; Kleinman, D; LeRoith, D; Levy, J; Roberts, CT; Sharoni, Y | 1 |
| Houghton, PJ; Luo, W; Sharif, M; Sharif, TR | 1 |
| Arai, N; Johnston, JA; Kamogawa, Y; Lee, HJ; McMahon, M; O'Garra, A | 1 |
| Reth, M; Wienands, J; Zhang, Y; Zürn, C | 1 |
| Bartholomew, PJ; DePasquale, JA; Vinci, JM | 1 |
| Gilmer, T; Risingsong, R; Sporn, MB; Suh, N; Wang, Y; Williams, CR; Willson, TM | 1 |
| May, FE; Molloy, CA; Westley, BR | 1 |
| Feng, W; Karin, M; Kushner, PJ; Li, J; Liu, X; Nguyen, P; Webb, P | 1 |
| Feustel, PJ; Kimelberg, HK; Mongin, AA; Osuka, K; Tranmer, BI | 1 |
| Consler, TG; Gray, JG; Iannone, MA; Parks, DJ; Pearce, KH; Stimmel, JB | 1 |
| Jebe, E; Petrunkina, AM; Töpfer-Petersen, E | 1 |
| Bagdasaryan, R; Davol, PA; Frackelton, AR; Hafer, LJ; Lu, L; Sgroi, DC | 1 |
| Arnaout, A; Chu, I; Hanna, W; Hengst, L; Kahn, H; Narod, S; Slingerland, J; Sun, J; Sun, P; Tan, CK | 1 |
| Edgerton, SM; Fan, Z; Liu, B; Ordonez-Ercan, D; Thor, AD; Yang, X | 1 |
| Band, H; Cook, SJ; Wiggins, CM | 1 |
| Ghafourifar, P; Parihar, A; Parihar, MS | 1 |
| Planas-Silva, MD; Zhao, Y | 1 |
| Kim, M; Kwon, SH; Mostov, KE; O'Brien, LE | 1 |
| Murphy, LC; Nugent, Z; Skliris, GP; Watson, PH | 1 |
| Alimirah, F; Hawthorne, M; Kalra, A; Kopelovich, L; Mehta, RG; Mehta, RR; Peng, X; Roy, S | 1 |
| Chao, A; Hsueh, S; Lai, CH; Lin, CY; Lin, YJ; Tsai, CL; Wang, HS; Wang, TH; Wu, HM | 1 |
| Chen, G; Ma, S; Migliaccio, A; Suresh, PS | 1 |
| Hachisuga, T; Inagaki, H; Kawagoe, T; Obara, G; Takahashi, K; Toyohira, Y; Tsutsui, M; Ueno, S; Yanagihara, N | 1 |
| Baharani, A; Lukong, KE; Mandapati, A; Ning, Z | 1 |
27 other study(ies) available for tyrosine and tamoxifen
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Correlation between tyrosine hydroxylase activity, melanogenesis, and estradiol binding in human melanoma cells.
Topics: Breast Neoplasms; Cell Line; Cytosol; Estradiol; Fibroblasts; Humans; Kinetics; Levodopa; Melanins; Melanoma; Tamoxifen; Tyrosine; Tyrosine 3-Monooxygenase | 1982 |
MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo.
Topics: Blotting, Western; Breast Neoplasms; Cell Division; DNA, Neoplasm; Estrogens; Flow Cytometry; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Neoplasms, Hormone-Dependent; Phosphorylation; Receptor, ErbB-2; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen; Transfection; Tumor Cells, Cultured; Tyrosine; Up-Regulation | 1995 |
Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins.
Topics: Antineoplastic Agents, Hormonal; Cell Division; Endometrial Neoplasms; Estrogen Antagonists; Female; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Phosphorylation; Piperidines; Raloxifene Hydrochloride; Receptor, IGF Type 1; Tamoxifen; Tumor Cells, Cultured; Tyrosine | 1996 |
CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Topics: Astrocytoma; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; Cyclic AMP Response Element-Binding Protein; Enzyme Activation; Enzyme Inhibitors; Humans; Indoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-fos; Staurosporine; Substance P; Tamoxifen; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tyrosine | 1997 |
A conditionally active form of STAT6 can mimic certain effects of IL-4.
Topics: Animals; Cell Line; DNA-Binding Proteins; Genetic Vectors; Humans; Interferon-gamma; Interleukin-4; Mice; Phosphorylation; Receptors, IgE; Recombinant Fusion Proteins; Retroviridae; Signal Transduction; STAT1 Transcription Factor; STAT6 Transcription Factor; Tamoxifen; Trans-Activators; Transcriptional Activation; Tyrosine; Up-Regulation | 1998 |
Induction of the antigen receptor expression on B lymphocytes results in rapid competence for signaling of SLP-65 and Syk.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Sequence; B-Lymphocytes; Base Sequence; Biological Transport; Carrier Proteins; Cell Line; Enzyme Precursors; Gene Expression Regulation; Integrases; Intracellular Signaling Peptides and Proteins; Molecular Sequence Data; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; Receptors, Antigen, B-Cell; Recombination, Genetic; Signal Transduction; src-Family Kinases; Syk Kinase; Tamoxifen; Transfection; Tyrosine; Vanadates; Viral Proteins | 1998 |
Decreased tyrosine phosphorylation of focal adhesion kinase after estradiol treatment of MCF-7 human breast carcinoma cells.
Topics: Breast Neoplasms; Cell Adhesion; Cell Adhesion Molecules; Cytoskeletal Proteins; Dimethyl Sulfoxide; Estradiol; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Paxillin; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured; Tyrosine | 1998 |
A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Drug Screening Assays, Antitumor; Female; Ligands; Mammary Neoplasms, Experimental; Methylnitrosourea; Oxazoles; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Tamoxifen; Transcription Factors; Tyrosine | 1999 |
Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line.
Topics: Adaptor Proteins, Signal Transducing; Blotting, Northern; Cell Division; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogens; Humans; Immunoblotting; Insulin; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Phosphoproteins; Phosphorylation; Receptor, IGF Type 1; RNA; Tamoxifen; Time Factors; Tumor Cells, Cultured; Tyrosine; Up-Regulation | 2000 |
Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway.
Topics: CREB-Binding Protein; Drug Synergism; Enzyme Activation; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nuclear Proteins; Nuclear Receptor Coactivator 2; Nuclear Receptor Coactivators; Oncogene Protein pp60(v-src); Phosphorylation; Protein-Tyrosine Kinases; Proteins; Receptors, Estrogen; Response Elements; Serine; Signal Transduction; Structure-Activity Relationship; Tamoxifen; Trans-Activators; Transcription Factors; Transcription, Genetic; Transfection; Tyrosine; Vitellogenins | 2001 |
Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat.
Topics: Animals; Brain; Cerebral Cortex; Disease Models, Animal; Enzyme Inhibitors; Indazoles; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley; Reference Values; Superoxides; Tamoxifen; Tyrosine | 2001 |
Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.
Topics: Amino Acid Motifs; Benzophenones; Cyclic AMP Response Element-Binding Protein; Estradiol; Estrogen Receptor beta; Histone Acetyltransferases; Humans; Ligands; Microspheres; Molecular Sequence Data; Nuclear Receptor Coactivator 1; Peptides; Protein Binding; Raloxifene Hydrochloride; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Tamoxifen; Transcription Factors; Tyrosine | 2001 |
Regulatory and necrotic volume increase in boar spermatozoa.
Topics: Animals; Annexin A5; Cell Size; Chloride Channels; Enzyme Inhibitors; Hypertonic Solutions; Male; Necrosis; Phenols; Phosphoprotein Phosphatases; Phosphorylation; Protein-Tyrosine Kinases; Quinidine; Semen Preservation; Spermatozoa; Staining and Labeling; Staurosporine; Swine; Tamoxifen; Tyrosine; Vanadates | 2005 |
p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Female; Humans; Neoplasm Recurrence, Local; Phosphoproteins; Phosphorylation; Protein Isoforms; Receptors, Estrogen; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Tamoxifen; Tyrosine | 2006 |
p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cell Transformation, Neoplastic; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Drug Resistance, Neoplasm; Feedback, Physiological; Female; Humans; Phosphorylation; Protein Binding; Proto-Oncogene Proteins pp60(c-src); Tamoxifen; Tyrosine | 2007 |
Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.
Topics: Animals; Apoptosis; Breast Neoplasms; Down-Regulation; Drug Resistance, Neoplasm; Female; Humans; Mammary Neoplasms, Experimental; Mice; Phosphorylation; Receptor, ErbB-2; Receptor, ErbB-3; RNA, Small Interfering; Tamoxifen; Tyrosine | 2007 |
c-Cbl is not required for ERK1/2-dependent degradation of BimEL.
Topics: Animals; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Cell Line; Enzyme Inhibitors; Epidermal Growth Factor; Epithelial Cells; Fibroblasts; Humans; Membrane Proteins; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Phosphorylation; Proteasome Endopeptidase Complex; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-cbl; Serine; Tamoxifen; Tyrosine; Ubiquitin; Vanadates | 2007 |
Significance of mitochondrial calcium and nitric oxide for apoptosis of human breast cancer cells induced by tamoxifen and etoposide.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Calcium; Cell Line, Tumor; Cytochromes c; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Membrane Potential, Mitochondrial; Mitochondria; Nitric Oxide; Tamoxifen; Time Factors; Tyrosine | 2008 |
Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity.
Topics: beta Catenin; Breast Neoplasms; Cadherins; Cell Adhesion; Cell Line, Tumor; CSK Tyrosine-Protein Kinase; Drug Resistance, Neoplasm; Estrogen Antagonists; Estrogen Receptor Modulators; Humans; Phosphorylation; Protein-Tyrosine Kinases; src-Family Kinases; Tamoxifen; Tyrosine | 2009 |
STAT1 is required for redifferentiation during Madin-Darby canine kidney tubulogenesis.
Topics: Animals; Cell Culture Techniques; Cell Differentiation; Cell Line; Dogs; Enzyme Activation; Epithelial Cells; Epithelial-Mesenchymal Transition; Green Fluorescent Proteins; Hepatocyte Growth Factor; Immunoblotting; Kidney; Kidney Tubules; Mutation; Organogenesis; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-raf; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; STAT1 Transcription Factor; Tamoxifen; Tyrosine | 2010 |
Estrogen receptor alpha phosphorylated at tyrosine 537 is associated with poor clinical outcome in breast cancer patients treated with tamoxifen.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Estrogen Receptor alpha; Female; Follow-Up Studies; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Multivariate Analysis; Phosphorylation; Receptor, ErbB-2; Tamoxifen; Tissue Array Analysis; Treatment Outcome; Tyrosine | 2010 |
PPARγ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significance.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Anilides; Animals; Anticarcinogenic Agents; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Oxazoles; PPAR gamma; Precancerous Conditions; Receptors, Progesterone; Tamoxifen; Tissue Culture Techniques; Transcriptional Activation; Tyrosine | 2013 |
Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Neoplasms; ErbB Receptors; Estradiol; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression; Humans; Phosphatidylinositol 3-Kinases; Phosphorylation; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; src-Family Kinases; Tamoxifen; Tyrosine | 2013 |
Protein-tyrosine phosphatase H1 increases breast cancer sensitivity to antiestrogens by dephosphorylating estrogen receptor at Tyr537.
Topics: Breast Neoplasms; Cell Line, Tumor; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Humans; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 3; Tamoxifen; Tyrosine | 2014 |
Effects of selective estrogen receptor modulators on plasma membrane estrogen receptors and catecholamine synthesis and secretion in cultured bovine adrenal medullary cells.
Topics: Acetylcholine; Adrenal Medulla; Animals; Calcium; Catecholamines; Cattle; Cell Membrane; Cells, Cultured; Dose-Response Relationship, Drug; Oocytes; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Sodium; Tamoxifen; Tyrosine; Xenopus | 2014 |
BRK confers tamoxifen-resistance in breast cancer via regulation of tyrosine phosphorylation of CDK1.
Topics: Breast Neoplasms; CDC2 Protein Kinase; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Phosphorylation; Protein-Tyrosine Kinases; Signal Transduction; Tamoxifen; Tyrosine | 2023 |